Neurology Updates

Presently, a number of CAR T cell therapies are authorized and utilized for cancer immunotherapy, targeting either CD19 or B cell maturation antigen…

Rozanolixizumab is subcutaneous infused monoclonal antibody targeting the neonatal Fc receptor (FcRn) in adult with MG.

As already presented…

An interim analysis of the phase 3 open-label extension study (RAISE-XT) testing zilucoplan (a self-administered subcutaneous complement C5 inhibitor)…

Eculizumab (Soliris; Alexion) is an intravenous complement C5 inhibitor originally approved by FDA and EMA in adult’s patient with anti-acetylcholine…

Neuromuscular diseases are a group of heterogenic rare conditions, that can be due to a genetic cause, inflammatory processes or dysimmune disorders.…

An integrated approach, merging accurate genetic and clinical data, is critical to properly study the effect of new treatments in FSHD.

Dear colleagues, 

we would like to drive your attention to the recent developments in Spinal Muscular Atrophy. Two different approaches (use of…

The use of statins in neurocardiovascular conditions has widely increased over the decades. Based on extension of indications major side effects of…